Dr. Vanbergen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4440 W 95th St
Ste 1100H
Oak Lawn, IL 60453Phone+1 708-684-5580Fax+1 708-684-4068
Education & Training
- Advocate Health Care/Advocate Children’s Hospital (Oak Lawn)Fellowship, Pediatric Cardiology, 2002 - 2005
- University of MinnesotaResidency, Pediatrics, 1998 - 2002
- University of Minnesota Medical SchoolClass of 1998
Certifications & Licensure
- IL State Medical License 2002 - 2026
- MN State Medical License 1999 - 2005
- American Board of Pediatrics Pediatric Cardiology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery Start of enrollment: 2016 Feb 01
- Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure Start of enrollment: 2016 Nov 16
- National Collaborative to Improve Care of Children With Complex Congenital Heart Disease Start of enrollment: 2016 May 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsAdapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.Deepa H. Kumbar, Andrew VanBergen, Catherina Ocampo, Sunthorn Muangmingsuk, Andrew J. Griffin
Journal of Applied Physiology. 2007-01-25
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: